Backed by Bayer Spain, Barcelona’s Right Care Foundation (RCF) is using Auckland’s Toku Eyes’ AI platform to train doctors in early detection of diseases through retinal imaging.
‘EyeCloud’, a pilot study of Toku Eyes’ technology, will be conducted at Consorci Hospitalari de Vic, where 13,000 patients a year are eligible for diabetic macular oedema screening. In the past, just 2,500 patients (19.2%) were screened and 5-7% referred to the ophthalmology service, said Auckland University Associate Professor Ehsan Vaghefi, Toku Eyes’ CEO.







